Liangyi Qie
Overview
Explore the profile of Liangyi Qie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cui X, Lu W, Zhang D, Qie L, Li H, Li X, et al.
Front Cardiovasc Med
. 2022 Oct;
9:991586.
PMID: 36204579
Aim: Selexipag is an oral selective prostacyclin receptor agonist approved for treatment of patients with pulmonary arterial hypertension (PAH). In the present study, we aim to assess the safety and...
2.
Ren J, Sun J, Ning F, Pang Z, Qie L, Qiao Q
J Am Soc Hypertens
. 2015 Nov;
9(12):951-8.
PMID: 26542414
The aim of the study was to study the associations of hypertension with gamma-glutamyltransferase (GGT) and alanine aminotransferase (ALT) levels. Data of 3575 men and 5504 women were analyzed. Multivariate...
3.
Meng X, Qie L, Wang Y, Zhong M, Li L
Clin Invest Med
. 2009 Dec;
32(6):E238.
PMID: 20003828
Purpose: Several studies have shown arterial stiffness changes associated with coronary artery disease (CAD). Recently, statins were reported to improve arterial stiffness. The aim of the study was to evaluate...
4.
Qie L, Meng X, Wang Y, Feng M, Zhong M, Li L
Clin Cardiol
. 2008 Aug;
31(11):551-5.
PMID: 18727111
Background: Several studies have shown regional left ventricular (LV) systolic and diastolic changes associated with coronary artery disease (CAD). Statins may have beneficial pleiotropic effects in addition to their lipid-lowering...